Tempus AI gained 31.9% over a week on Medicare reimbursement commentary, not its genome platform

SentiSense · Published · Updated

Tempus AI rose 31.9% over the past week, a move Seoul Economic Daily attributes to CEO Eric Lefkofsky's September 15 remarks at the Morgan Stanley Hea...

Sign in to read the full story. Free accounts include 20 full reads a month.

Sign in or create a free account

Powered by SentiSense - Intelligent Market Analysis